Coronary Artery Restenosis Completed Phase 1 / 2 Trials for Paclitaxel (DB01229)

Also known as: Restenosis, Coronary / Coronary Restenosis

IndicationStatusPhase
DBCOND0032386 (Coronary Artery Restenosis)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00124943Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent RestenosisTreatment